Abnormal Circulating Short Chain Fatty Acid Concentration C5421641
An abnormal level of short-chain fatty acids in the blood, which are important for gut health. It can occur in people with digestive disorders or metabolic conditions. Treatment focuses on addressing the underlying cause and may include dietary changes.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Irregular heartbeat
Abnormal heart rhythm or palpitations due to electrolyte imbalances from chronic gastrointestinal disturbances.
Seek immediate medical attention for chest pain, severe palpitations, shortness of breath, or fainting.
Diarrhea
(gastrointestinal)Frequent loose or watery stools due to altered gut motility and fermentation processes from abnormal SCFA levels.
Frequency: 70-80% of patients
Fatigue
(constitutional)Persistent tiredness and low energy levels resulting from impaired energy metabolism and reduced ATP production.
Frequency: 75-85% of patients
Abdominal bloating
(gastrointestinal)Feeling of fullness and swelling in the abdomen due to disrupted gut fermentation and gas production.
Frequency: 55-65% of patients
Cognitive difficulties
(neurologic)Trouble concentrating, memory issues, and mental fog due to reduced SCFA transport across the blood-brain barrier.
Frequency: 50-60% of patients
Elevated blood glucose
(metabolic)Higher than normal blood sugar levels due to impaired SCFA-mediated glucose metabolism regulation.
Frequency: 20-30% of patients
Unexplained weight loss
(constitutional)Unintentional weight loss due to malabsorption and altered nutrient metabolism from abnormal SCFA levels.
Frequency: 15-25% of patients
Joint pain
(musculoskeletal)Pain and stiffness in joints due to systemic inflammation from altered SCFA anti-inflammatory effects.
Frequency: 15-20% of patients
Skin inflammation
(dermatologic)Red, itchy, or inflamed skin patches due to systemic inflammatory changes from abnormal SCFA metabolism.
Frequency: 5-10% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Prebiotic fiber supplementation
Increased intake of fermentable dietary fibers from fruits, vegetables, and whole grains to support colonic production of short-chain fatty acids including acetate, propionate, and butyrate.
Probiotic therapy
Administration of probiotic strains specifically selected to enhance short-chain fatty acid production, such as strains of Lactobacillus and Bifidobacterium.
Additional treatment options
Gut motility optimization
Regular physical activity and hydration to support healthy intestinal transit time, allowing adequate fermentation and SCFA production.
lifestyleFecal SCFA and microbiome analysis
Laboratory assessment of stool samples to measure short-chain fatty acid concentrations and gut microbiome composition for treatment guidance.
monitoringButyrate supplementation
Direct oral supplementation with butyrate or butyrate-producing compounds when endogenous SCFA production remains inadequate despite dietary and probiotic interventions.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Short Chain Fatty Acid Concentration C5421641?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and metabolic homeostasis. J Clin Endocrinol Metab. 2015;100(7):2849-2858.
Huang W, Man Y, Gao C, et al. Short-chain fatty acids ameliorate diabetic nephropathy via GPR109A-mediated renal inflammation inhibition. Front Pharmacol. 2022;13:1045502.
Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships between gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600-605.
Blaak EE, Canfora EE, Theis S, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes. 2020;11(5):411-455.
Puddu A, Sanguineti R, Montecucco F, Viviani GL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Int J Mol Sci. 2014;15(11):21487-21499.
Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91-119.
American Diabetes Association. 3. Prevention or delay of type 2 diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S40-S52.
American Gastroenterological Association. AGA Position Statement: Short-Chain Fatty Acids and Gut Health. Gastroenterology. 2022;163(1):302-314.
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332-1345.
Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189-200.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Short Chain Fatty Acid Concentration C5421641. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy